MDA Pays RTX $267M to Restart SM-3 Block IB Production Line

The Missile Defense Agency just formalized what it quietly decided months ago: it will pay to restart the SM-3 Block IB production line rather than rely solely on the newer Block IIA variant or allied supply. The $266.9M modification definitizes two prior undefinitized actions and brings the total contract to 78 all-up rounds. The line-item that matters is buried in the award language—MDA is explicitly funding the one-time costs to bring Block IB manufacturing back online.¹²

This is a programmatic pivot, not a contractor win. RTX is the sole U.S. prime for SM-3; the award was not competed.⁵ What changed is MDA's calculus. The agency had been winding down Block IB production in favor of the larger, two-stage Block IIA developed jointly with Japan.⁶ Restarting a mothballed line requires non-recurring expenditures: tooling, supplier re-qualification, test infrastructure, workforce. MDA decided those costs were cheaper or faster than the alternative.

Operational demand drove the decision. SM-3s saw heavy use in Red Sea intercepts starting in late 2023, and inventory drawdown highlighted a theater missile defense gap that Block IIA deliveries alone could not immediately fill.³⁴ The unit economics are brutal. Independent analysis pegged Block IB costs at roughly $9M per interceptor in 2021; recent figures approach $24M.³ The restart premium makes that worse in the near term, but MDA judged speed more valuable than unit price. The Pentagon's broader missile production agreements with RTX, announced in early February, confirmed the government will cooperatively fund restart costs across multiple programs.¹²

The restart creates a supply-chain market. One-time restart investments flow to propellant manufacturers, guidance component suppliers, divert and attitude control system vendors, avionics test houses. Companies that can reduce non-recurring engineering costs or accelerate line standup are suddenly relevant. The contract also surfaces a procurement trade: MDA is willing to pay higher short-term costs to restore capacity quickly, which raises lifecycle budgeting questions and oversight risk on the Hill. The SM-3 program now has two active production lines, different cost structures, and overlapping theater missions.⁷ That complexity is the price of responsiveness.